Spanning binding sites on allosteric proteins with polymer-linked ligand dimers

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Molecular Biology

Background:

• Traditional drug design relies on protein structure determination or random screening.
• Developing potent ligands for proteins with multiple binding sites presents a challenge.
• Existing methods may require extensive structural information or lack specificity.

Purpose of the Study:

• To develop a novel strategy for creating potent and selective ligands for proteins with multiple binding sites.
• To investigate the efficacy of polymer-linked ligand dimers in activating specific protein targets.
• To demonstrate a method for identifying optimal ligand structures without prior protein structural data.

Main Methods:

• Synthesized polymer-linked ligand dimers by joining two ligands with a variable-length polymer chain.
• Tested the potency of cyclic GMP-containing dimers against cyclic-nucleotide-gated channels and cGMP-dependent protein kinase.
• Empirically selected optimal polymer lengths for different target proteins.

Main Results:

• Polymer-linked ligand dimers with cyclic GMP moieties were up to 1000 times more potent than cyclic GMP alone.
• Each target protein exhibited an optimal polymer length for dimer activity, despite conserved binding sites.
• The optimal polymer length provided an estimate of the distance between protein binding sites.

Conclusions:

• The polymer-linked ligand dimer strategy offers a potent and selective approach to drug discovery.
• This method bypasses the need for detailed structural information of target proteins.
• Tuning polymer length allows for the empirical identification of effective ligands based on binding site spacing.